We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
Cap. Flow
-$21B
Cap. Flow %
-11.12%
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Healthcare 11.06%
3 Financials 8.17%
4 Consumer Discretionary 8.09%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUE icon
4051
Cue Biopharma
CUE
$112M
$252K ﹤0.01%
721
-44
-6% -$17.1K
DSPG
4052
DELISTED
DSP Group Inc
DSPG
$252K ﹤0.01%
17,019
+202
+1% +$3.02K
MOFG
4053
DELISTED
MidWestOne Financial Group
MOFG
$251K ﹤0.01%
8,720
-1,291
-13% -$39.7K
USMV icon
4054
iShares MSCI USA Min Vol Factor ETF
USMV
$23.9B
$250K ﹤0.01%
+3,400
New +$246K
GTH
4055
DELISTED
Genetron Holdings Limited ADS
GTH
$250K ﹤0.01%
+4,136
New +$255K
GOL
4056
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$248K ﹤0.01%
26,686
+1,504
+6% +$14K
FOR icon
4057
Forestar Group
FOR
$1.49B
$247K ﹤0.01%
11,877
-36,154
-75% -$846K
VERI icon
4058
Veritone
VERI
$111M
$245K ﹤0.01%
+12,496
New +$271K
POSH
4059
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$243K ﹤0.01%
+5,105
New +$219K
ADVM
4060
DELISTED
Adverum Biotechnologies
ADVM
$241K ﹤0.01%
6,886
+40
+0.6% +$2.15K
ONLN icon
4061
ProShares Online Retail ETF
ONLN
$67.3M
$241K ﹤0.01%
+2,986
New +$234K
BCAB icon
4062
BioAtla
BCAB
$5.58M
$240K ﹤0.01%
+113
New +$255K
ONTF
4063
DELISTED
ON24
ONTF
$240K ﹤0.01%
+6,392
New +$250K
AUD
4064
DELISTED
Audacy, Inc.
AUD
$240K ﹤0.01%
56,621
-82,630
-59% -$380K
BHB icon
4065
Bar Harbor Bankshares
BHB
$682M
$239K ﹤0.01%
8,368
+63
+0.8% +$1.86K
VITL icon
4066
Vital Farms
VITL
$512M
$239K ﹤0.01%
11,980
+646
+6% +$14.3K
BF.A icon
4067
Brown-Forman Class A
BF.A
$13.1B
$237K ﹤0.01%
+3,316
New +$236K
VKTX icon
4068
Viking Therapeutics
VKTX
$3.9B
$237K ﹤0.01%
39,587
-25,566
-39% -$152K
AB icon
4069
AllianceBernstein
AB
$3.47B
$236K ﹤0.01%
5,126
-14,075
-73% -$613K
EVBN
4070
DELISTED
Evans Bancorp Inc
EVBN
$236K ﹤0.01%
+6,370
New +$232K
EVER icon
4071
EverQuote
EVER
$822M
$235K ﹤0.01%
7,215
-408
-5% -$13.6K
CROC
4072
DELISTED
ProShares UltraShort Australian Dollar
CROC
$235K ﹤0.01%
5,121
-85
-2% -$3.72K
HL icon
4073
CALL
Hecla Mining
HL
$10.4B
$234K ﹤0.01%
32,000
PAM icon
4074
Pampa Energía
PAM
$4.56B
$234K ﹤0.01%
15,631
-12,300
-44% -$186K
HZNP
4075
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$234K ﹤0.01%
+2,500
New +$230K

Similar funds

Credit Suisse's Q2 2021 Portfolio in Review

As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.

  • Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
  • Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
  • Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
  • Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
  • Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
  • Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
  • Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.